AR029984A1 - METHOD FOR REDUCING ASSOCIATED EXCERBATIONS COPD AMBITO - Google Patents

METHOD FOR REDUCING ASSOCIATED EXCERBATIONS COPD AMBITO

Info

Publication number
AR029984A1
AR029984A1 ARP010103546A ARP010103546A AR029984A1 AR 029984 A1 AR029984 A1 AR 029984A1 AR P010103546 A ARP010103546 A AR P010103546A AR P010103546 A ARP010103546 A AR P010103546A AR 029984 A1 AR029984 A1 AR 029984A1
Authority
AR
Argentina
Prior art keywords
copd
excerbations
ambito
reducing associated
reducing
Prior art date
Application number
ARP010103546A
Other languages
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR029984A1 publication Critical patent/AR029984A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente se refiere a un método para reducir la frecuencia y/o la gravedad de las exacerbaciones de COPD mediante la administracion de un inhibidor de la fosfodiesterasa 4 (PDE4).This refers to a method to reduce the frequency and / or severity of COPD exacerbations by administering a phosphodiesterase 4 (PDE4) inhibitor.

ARP010103546A 2000-07-27 2001-07-25 METHOD FOR REDUCING ASSOCIATED EXCERBATIONS COPD AMBITO AR029984A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22127500P 2000-07-27 2000-07-27

Publications (1)

Publication Number Publication Date
AR029984A1 true AR029984A1 (en) 2003-07-23

Family

ID=22827112

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103546A AR029984A1 (en) 2000-07-27 2001-07-25 METHOD FOR REDUCING ASSOCIATED EXCERBATIONS COPD AMBITO

Country Status (16)

Country Link
EP (1) EP1320361A4 (en)
JP (1) JP2004505039A (en)
KR (1) KR20030019620A (en)
CN (1) CN1444476A (en)
AR (1) AR029984A1 (en)
AU (2) AU7902301A (en)
BR (1) BR0112682A (en)
CA (1) CA2417336A1 (en)
CZ (1) CZ2003141A3 (en)
HU (1) HUP0300685A3 (en)
IL (1) IL153919A0 (en)
MX (1) MXPA03000714A (en)
NO (1) NO20030332D0 (en)
PL (1) PL365612A1 (en)
WO (1) WO2002009689A1 (en)
ZA (1) ZA200300476B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
DE10110772A1 (en) * 2001-03-07 2002-09-12 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics and PDE-IV inhibitors
GB0118373D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Novel therapeutic method
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DE10230769A1 (en) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug compositions based on new anticholinergics and PDE-IV inhibitors
DE602004023921D1 (en) 2003-03-10 2009-12-17 Nycomed Gmbh NEW PROCESS FOR THE PRODUCTION OF ROLUMUMILAST
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
KR102087661B1 (en) * 2018-07-27 2020-03-11 강원대학교산학협력단 Composition for prevention or treatment of chronic obstructive pulmonary disease comprising GEBR-7B compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (en) * 1999-03-01 2005-05-20 Smithkline Beecham Corp Use of a pde4 inhibitor in the preparation of a drug against copd.
SE9902937D0 (en) * 1999-08-18 1999-08-18 Astra Pharma Prod Pharmaceutical compositions
BR0015039A (en) * 1999-10-29 2002-06-25 Smithkline Beecham Corp Method for administering a phosphodiesterase 4 inhibitor

Also Published As

Publication number Publication date
KR20030019620A (en) 2003-03-06
JP2004505039A (en) 2004-02-19
BR0112682A (en) 2003-06-24
HUP0300685A2 (en) 2003-12-29
WO2002009689A1 (en) 2002-02-07
CZ2003141A3 (en) 2004-07-14
PL365612A1 (en) 2005-01-10
CN1444476A (en) 2003-09-24
NO20030332L (en) 2003-01-22
NO20030332D0 (en) 2003-01-22
ZA200300476B (en) 2004-04-23
AU7902301A (en) 2002-02-13
CA2417336A1 (en) 2002-02-07
HUP0300685A3 (en) 2004-10-28
IL153919A0 (en) 2003-07-31
EP1320361A1 (en) 2003-06-25
MXPA03000714A (en) 2003-06-04
EP1320361A4 (en) 2006-04-05
AU2001279023B2 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
NO20042080L (en) Inhibitors of post-proline cleavage proteases
ECSP034519A (en) XANTINA PHOSPHODIESTERASE V INHIBITORS
NO20035603D0 (en) Fluoropyrrolidines as dipeptidyl peptidase inhibitors
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
AR029984A1 (en) METHOD FOR REDUCING ASSOCIATED EXCERBATIONS COPD AMBITO
BR0317139A (en) Methods and compounds for the production of dipeptidyl peptidase iv inhibitors and their intermediates
UY26942A1 (en) PROMOTING N-ACILSULFONAMIDS OF APOPTOSIS
BRPI0411900A (en) antiviral compounds and methods
BR0317715A (en) Compositions and processes of use of collajolie
ATE328476T1 (en) METHOD FOR IMPROVING REPRODUCTIVE PERFORMANCE IN POULTRY
YU5503A (en) Non-steroidal inflammation inhibitors
JP2005511541A5 (en) Inhibitor of post proline cleavage protease
ATE490253T1 (en) SYNTHESIS OF 5-SUBSTITUTED 7-AZAINDOLINES AND 7-AZAINDOLINES
AP2001002205A0 (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
HK1070008A1 (en) Combination of cytochome p 450 dependent protease inhibitors
WO2002060869A3 (en) Use of p38 inhibitors for the treatment of inflammation-enhanced cough
WO2001056573A8 (en) Use of cox-2 inhibitors as gastroprokinetics
GB0011358D0 (en) Novel use
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
BR0213126A (en) 6-membered unsaturated heterocyclic compounds useful for selective inhibition of coagulation cascade
AP2001002248A0 (en) Method for treating COPD.
BR9808923B1 (en) processes for making cyclooxygenase-2 inhibitor compounds, and intermediate compounds for making cyclooxygenase-2 inhibitors.
WO2002051848A3 (en) Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
DE602004007409D1 (en) Method for connecting at least two members
BR0009453B1 (en) process for the preparation of a compound.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal